During the past decade, ORA, Inc conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 16 clinical trials were completed, i.e. on average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ORA, Inc" #1 sponsor was "Aciex Therapeutics, Inc." with 5 trials, followed by "ORA, Inc." with 5 trials sponsored, "Bausch & Lomb Incorporated" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Eye Therapies, LLC" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ORA, Inc" #1 collaborator was "ORA, Inc." with 2 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 2 trials as a collaborator and "MacuSight, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ORA, Inc" are "Allergic Conjunctivitis" (15 trials), "Dry Eye" (5 trials), "Psoriasis" (3 trials), "Allergic Rhinitis" (2 trials) and "Blepharitis" (2 trials). Many other conditions were trialed in "ORA, Inc" in a lesser frequency.

Most popular intervention types in "ORA, Inc" are "Drug" (32 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Vehicle" (5 trials), "AC-170 0%" (4 trials), "AC-170 0.24%" (3 trials) and "Ketotifen" (2 trials). Other intervention names were less common.

The vast majority of trials in "ORA, Inc" are 35 trials for "All" genders.

Currently, there are NaN active trials in "ORA, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in ORA, Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ORA, Inc, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".